Literature DB >> 12181716

Postoperative hyperbilirubinemia after surgery for gastrointestinal perforation.

Toshirou Nishida1, Nobuhiro Fujita, Tadashi Megawa, Masaaki Nakahara, Kazuyasu Nakao.   

Abstract

PURPOSE: The aim of this study was to evaluate the risk factors and outcome of patients with hyperbilirubinemia after surgery for generalized peritonitis.
METHODS: We retrospectively analyzed data from 229 patients with generalized peritonitis caused by gastrointestinal (GI) perforations.
RESULTS: Postoperative hyperbilirubinemia defined as a value of > or =5 mg/dl, within 1 month, developed in 39 patients. Postoperative hyperbilirubinemia was related to age ( P = 0.0102), poor nutritional status ( P = 0.0388), decreased base excess ( P = 0.0037), delay until surgery ( P = 0.0276), preoperative serum bilirubin ( P = 0.0321) and postoperative persistent infection ( P < 0.0001). Higher mortality was seen in patients with hyperbilirubinemia (59%) than in those without hyperbilirubinemia (4%). The patients with hyperbilirubinemia who survived had decreased serum bilirubin levels after 3-5 postoperative days whereas a continuous increase was seen in the patients who ultimately died. Preoperative shock ( P = 0.0003), a decreased preoperative platelet count ( P = 0.0152), postoperative infection ( P = 0.0050), and postoperative hyperbilirubinemia ( P < 0.0001) were risk factors for overall mortality.
CONCLUSION: These results indicate that postoperative hyperbilirubinemia in patients with GI perforation is related to persistent postoperative infection and associated with poor prognosis.

Entities:  

Mesh:

Year:  2002        PMID: 12181716     DOI: 10.1007/s005950200126

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  8 in total

1.  Comparative Evaluation of Intra-Operative Peritoneal Lavage with Super Oxidized Solution and Normal Saline in Peritonitis Cases; Randomized Controlled Trial.

Authors:  Rikki Singal; Siddharth Dhar; Muzzafar Zaman; Bir Singh; Varsha Singh; Sheena Sethi
Journal:  Maedica (Bucur)       Date:  2016-12

2.  Spectrum of perforation peritonitis.

Authors:  Sujit M Chakma; Rahul L Singh; Mahadev V Parmekar; K H Gojen Singh; Buru Kapa; K H Sharatchandra; Amenla T Longkumer; Santhosh Rudrappa
Journal:  J Clin Diagn Res       Date:  2013-11-10

3.  Serum total bilirubin elevation is a predictor of the clinicopathological severity of acute appendicitis.

Authors:  Satoshi Nomura; Masanori Watanabe; Osamu Komine; Takeshi Shioya; Tetsutaka Toyoda; Hideki Bou; Tetsuo Shibuya; Hideyuki Suzuki; Eiji Uchida
Journal:  Surg Today       Date:  2013-07-24       Impact factor: 2.549

4.  Peritonitis - the Eastern experience.

Authors:  Sanjay Gupta; Robin Kaushik
Journal:  World J Emerg Surg       Date:  2006-04-26       Impact factor: 5.469

5.  Association between trends in clinical variables and outcome in intensive care patients with faecal peritonitis: analysis of the GenOSept cohort.

Authors:  Ascanio Tridente; Geraldine M Clarke; Andrew Walden; Anthony C Gordon; Paula Hutton; Jean-Daniel Chiche; Paul A H Holloway; Gary H Mills; Julian Bion; Frank Stüber; Christopher Garrard; Charles Hinds
Journal:  Crit Care       Date:  2015-05-05       Impact factor: 9.097

6.  Hyperbilirubinemia as a predictor of severity of acute appendicitis.

Authors:  Masaaki Akai; Kazuhide Iwakawa; Yuichi Yasui; Yusuke Yoshida; Takuya Kato; Koji Kitada; Ryosuke Hamano; Naoyuki Tokunaga; Hideaki Miyaso; Yosuke Tsunemitsu; Shinya Otsuka; Masaru Inagaki; Hiromi Iwagaki
Journal:  J Int Med Res       Date:  2019-06-26       Impact factor: 1.671

7.  Hyperbilirubinemia is a significant indicator for the severity of acute appendicitis.

Authors:  Young Ran Hong; Chul-Woon Chung; Jong Woo Kim; Chang Il Kwon; Dae Ho Ahn; Sung Won Kwon; Seong Ki Kim
Journal:  J Korean Soc Coloproctol       Date:  2012-10-31

8.  Early Liver Dysfunction in Patients With Intra-Abdominal Infections.

Authors:  Kun Guo; Jianan Ren; Gefei Wang; Guosheng Gu; Guanwei Li; Xiuwen Wu; Jun Chen; Huajian Ren; Zhiwu Hong; Lei Wu; Guopu Chen; Deng Youming; Jieshou Li
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.